EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic profiling reveals complement activation in chronic pancreatitis adjacent to pancreatic ductal adenocarcinoma

Arun Kumar Selvam, Ville N Pimenoff, Carlos Fernández Moro, Soledad Pouso Elduayen, Joakim Dillner, Mikael Björnstedt, Mehran Ghaderi

Immunobiology · 2026-09 · 231 (5) · 153239

DOI: 10.1016/j.imbio.2026.153239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunobiology, 2026-09. Verfasst von Arun Kumar Selvam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Division of Pathology F46, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatitis, Chronic, Pancreatic Neoplasms, Complement Activation. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Innovative Medicine, Stockholm Cancer Society, Cancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC) frequently coexist, yet distinguishing inflammatory changes secondary to malignancy from primary pancreatitis remains challenging. Here, we present an integrated multi-omics analysis of spatially distinct pancreatic tissue compartments obtained from a single patient undergoing pancreaticoduodenectomy for PDAC, combining histopathology, transcriptomics, immunofluorescence, and meta-transcriptomic microbial profiling. Morphological assessment identified tumor tissue, adjacent CP, and normal pancreas. Transcriptomic profiling of macro-dissected samples revealed differential gene expression and enrichment of the classical complement pathway in the CP compartment, which was qualitatively supported by immunofluorescent detection of C1q and C3 along the ductal epithelium. Meta-transcriptomic analysis detected a limited number of bacterial taxa and no viral RNA; these findings were interpreted conservatively given the constraints of low-biomass tissue profiling and the single-patient design. Although causal inference and generalizability are limited by the single-patient design, this study demonstrates the feasibility of integrating pathology with transcriptomic and microbial analyses to generate a hypothesis-generating, multi-omics framework for exploring inflammatory-malignant interactions in pancreatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatitis, ChronicPancreatic NeoplasmsComplement ActivationHumansGene Expression ProfilingTranscriptomeMultiomics

Stichwörter der Autor:innen

And transcriptomicsComplement pathwayMicrobial profilingPancreatic ductal adenocarcinomaPancreatitis

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Division of Pathology F46, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.
  • Department of Clinical Science, Intervention and Technology (CLINTEC), ANA Futura, Karolinska Institutet, SE-141 52 Stockholm, Sweden; Unit of Population Health, University of Oulu, Aapistie 5a, Oulu, Finland.
  • Department of Laboratory Medicine, Division of Pathology F46, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital…
  • Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
  • Department of Clinical Science, Intervention and Technology (CLINTEC), ANA Futura, Karolinska Institutet, SE-141 52 Stockholm, Sweden; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospi…

Förderung

  • Center for Innovative Medicine
  • Stockholm Cancer Society
  • Cancerfonden
  • Radiumhemmets Forskningsfonder
  • Insamlingsstiftelsen Cancer- och Allergifonden
  • Alberta Law Foundation

Zitieren

APA

Selvam, A. K., Pimenoff, V. N., Moro, C. F., Elduayen, S. P., Dillner, J., Björnstedt, M., & Ghaderi, M. (2026). Transcriptomic profiling reveals complement activation in chronic pancreatitis adjacent to pancreatic ductal adenocarcinoma. Immunobiology, 231(5), 153239. https://doi.org/10.1016/j.imbio.2026.153239

Vancouver

Selvam AK, Pimenoff VN, Moro CF, Elduayen SP, Dillner J, Björnstedt M, et al. Transcriptomic profiling reveals complement activation in chronic pancreatitis adjacent to pancreatic ductal adenocarcinoma. Immunobiology. 2026;231(5):153239. doi:10.1016/j.imbio.2026.153239

BibTeX
@article{Selvam2026,
  author = {Selvam, Arun Kumar and Pimenoff, Ville N and Moro, Carlos Fernández and Elduayen, Soledad Pouso and Dillner, Joakim and Björnstedt, Mikael and Ghaderi, Mehran},
  title = {Transcriptomic profiling reveals complement activation in chronic pancreatitis adjacent to pancreatic ductal adenocarcinoma},
  journal = {Immunobiology},
  year = {2026},
  volume = {231},
  number = {5},
  pages = {153239},
  doi = {10.1016/j.imbio.2026.153239}
}
Kostenlos starten →